Grant winners - 14 February 2013

February 14, 2013

Leverhulme Trust

Research Project Grants

Ringtronics: single-molecule circuitry for electronics and spintronics

  • Award winner: Andrew Ellis
  • Institution: University of Leicester
  • Value: £122,734

Freezing complexes in helium nano-droplets: a unique tool for chemical dynamics

Social cognition and its relation to social development in neurodevelopmental disorders

  • Award winner: Pauline Schaap
  • Institution: University of Dundee
  • Value: £184,308

Regulation of eukaryote sessility by diguanylate cyclase

Social sciences

Conflicts in cultural value: localities and heritage in Southwestern China

Economic and Social Research Council

Future Research Leaders Scheme

  • Award winner: Katherine Smith
  • Institution: University of Edinburgh
  • Value: £172,556

A risky business? The politics of knowledge transfer in public health

  • Award winner: Laura Coroneo
  • Institution: University of York
  • Value: £159,992

Modelling government bonds: macroeconomic, financial and international linkages

  • Award winner: Leendert (Anne) ter Wal
  • Institution: Imperial College London
  • Value: £161,514

Strategic networking: how highly skilled professionals can best use their networks to drive innovation

  • Award winner: Richard Ramsey
  • Institution: Bangor University
  • Value: £173,468

When bodies and traits collide: investigating a “Who” system for social cognition

National Institute for Health Research

Health Technology Assessment Programme

  • Award winner: Jon Dorling
  • Institution: Nottingham University Hospitals NHS Trust
  • Value: £2,723,826

Speed of increasing milk feeds trial (Sift)

  • Award winner: Nicholas A. Francis
  • Institution: Cardiff University
  • Value: £1,083,208

Ostrich: Oral steroids for resolution of otitis media with effusion (OME) in children

In detail

Award winner: Usha Chakravarthy

Institution: Queen’s University Belfast

Value: £435,500

Echoes: the effectiveness of community vs hospital eye service follow-up for patients with neovascular age-related macular degeneration with quiescent disease

The “wet”, or neovascular, form of age-related macular degeneration is currently treated with drugs that control the condition in about 90 per cent of sufferers. This trial will test ophthalmologists’ and optometrists’ ability to make correct decisions about the need for anti- VEGF treatment in patients with wet AMD. Participants will assess the need from pictures of the affected part of the eye with accompanying clinical data, created from information collected in a NIHR-funded national trial of the effectiveness of anti-VEGF drugs, to mimic the characteristics of patients judged to be eligible for follow-up in the community. The project will assess whether participants’ judgements tally with independent grading of the pictures and expert medical opinion.

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments